Jul 21, 2026, 13:05
Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
Danai Poutakidou, Member (Alternate) of the Accreditation Commission for Medical Specialists in Clinical Biology, Head of Hematology Department at Brussels University Hospital Laboratory LHUB-ULB, shared a post on LinkedIn:
“Delighted to showcase the work of our LHUB‑ULB hemostasis team at ISTH2026.
This case underlines how expert analytical review and proper reagent selection help uncover a Lupus Anticoagulant behind an unexpected PT/INR prolongation, avoiding major diagnostic pitfalls.
Grateful to our hemostasis experts Kleio Ouzounelli and Mirvate Harb for their key contributions to this challenging and insightful investigation.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question